Sabinsa Global Expansion Continues: Opens Offices In Korea
Sabinsa Granted 67th Patent: Selenium Containing Dipeptides
Sabinsa's BioPerine® Validated In Resveratrol Pre-Clinical Study
Sabinsa Awarded Damages By US District Court: Creative Compounds Ordered To Pay For ForsLean® Trademark Infringement
Sabinsa Introduces Integrated Nutritional Composites™ (Inc) Bilayered Tablets
Sabinsa Stages Food Demo Of GRAS Ingredients At NPA Marketplace Trade Show
Latest Press Release
Sami-Sabinsa Group Elevates Dr. Anju Majeed to Group Executive Chairperson, Appoints Mr. Shaheen Majeed as the new Global Managing Director & CEO
Date: March 29, 2024
Dr. Muhammed Majeed (September 25, 1948 – March 13, 2024) Founder and Chairman, Sami-Sabinsa Group
Date: March 13, 2024
Sami-Sabinsa to Highlight Research on Shagandha™ Ashwagandha for Stress Management Benefits at Expo West 2024
Date: February 13, 2024
Sami-Sabinsa Gains First Approval for ANVISA’s IN28 in Brazil for C3 Reduct®
Date: January 17, 2024
Sabinsa Nanjing Expands into New Facility in Nanjing, China
Date: December 16, 2023